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Table 1. Comparison of D4 γ results, DC γ and DC DD for lung 
plans with and without density override (DO) in the body or 
lung volume. 
 
Conclusions: The DC EPID in vivo dosimetry system was 
successfully implemented at our hospital. Corresponding 
gamma pass/fail criteria for DC and D4 phantom 
measurements were established. A solution was found to 
overcome dose reconstruction issues in strong heterogeneous 
regions. The main limitation of the system remains the size 
of the EPID panel.  
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Purpose/Objective: The new commercial thermal neutron 
device (TNRD) has a good response with directionality in a 
pure neutron beam [1]. In addition, good coincidence with 
TLD detectors was found for peripheral neutron dose 
estimation in-phantom [2]. Nevertheless, further experiments 
have shown that TNRD is not completely reliable in some 
special clinical conditions, due to photon contribution. The 
aim of this work is the knowledge of uncertainties related to 
photon presence under different irradiation conditions, 
especially angle incidence influences at different field-edge 
distances. This will not only verify the goodness of TNRD 
measurements due to a possible compensation, but to find a 
possible correction to improve peripheral neutron doses 
estimation.  
Materials and Methods: TNRD detector is based on a pair of 
commercial photodiodes, and allows the measurement of 
thermal neutron fluences under an intense photon 
background [1]. However in the case of an in important 
photon presence, intrinsic differences among diodes make 
TNRD signal to be over or underestimated, due to their 
relative position with respect to the beam incidence. This 
could be a consequence of 'shadow' effect, from one diode to 
the other, as the reading is obtained by the subtraction of 
both signals (the one of the sensitized to neutrons and the 
normal one). Six gantry angle incidences (0º, 45º, 135º, 180º, 
225º and 315º) were measured in 6 and 15 MV for two 
different field-edge detector distances (10 and 25 cm, 
corresponding to an approx. dose rate 3.53 and 1.21 
cGy/min). A Primus Siemens linac using a 40x10 cm2 field was 
employed with TNRD detectors inserted in the middle of two 
layers of 4 cm polyethylene. 
Results: The table shows TNRD readings at 6 MV (photon 
signal) and neutron component from 15 MV (subtraction of 15 
MV and 6 MV readings). Photon influence in TNRD neutron 
readings are up to 50% for 315º and 135º for 10 cm. However 
if we consider the accumulated readings among the whole 
arc, total photon component is compensated and reduced to 
9.3% or 6.7% depending on distance to field-edge. The figure 
shows the compensation of photon component for 
complementary gantry angles. 
 
Table. (see text) 
 
 
Figure. TNRD readings for complementary gantry angles at a 
field-edge detector distance of 10 (dashed line) and 25 (solid 
line) cm.  
Conclusions: Results obtained here explain the problem that 
TNRD measurements have shown when measuring at some 
angle incidences at different distances to the field-edge 
because of photon contribution. The good relation obtained 
with TLD detectors in previous experiences [2] are due to the 
compensation of different angle incidences shown here. 
lthough good measurements are obtained when compensated 
multi-incidences are used, more accurate results would be 
obtained if 6 and 15 MV measurements are performed under 
the same conditions. This would be relevant when non-
balanced gantry incidences are used.  
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Purpose/Objective: We propose a Quality Assurance (QA) 
procedure for a Volumatric Intensity Modulated Arc Therapy 
(VMAT) delivery technique namely Rapid Arc by dividing a 
complete arc into sub arc plans and verify fluence using the 
amorphous silicon electronic portal imaging device (a-Si EPID) 
for measurements. 
Materials and Methods: The introduction of advanced 
irradiation techniques in a radiotherapy clinic requires 
extensive dose verification measures that go beyond current 
routine clinical practice. Rapid Arc is a VMAT technology 
developed by M/s Varian medical Systems. A Rapid Arc (RA) 
treatment plan is made possible by a treatment planning 
algorithm that simultaneously changes three parameters 
during treatment, i) rotation speed of the gantry ii) shape of 
the treatment aperture using the movement of multileaf 
collimator leaves, and iii) delivery dose rate. Due to the 
complexity of treatment planning and delivery there is a 
necessity of dosimetric verification of a RapidArc plan. 
Generally, this verification is carried out using ion chambers, 
diodes, films, 2D array & other tools which is cumulative in 
nature and also time consuming. In this study we created a 
RapidArc QA plan using Eclipse-10 (Varian medical Systems) 
treatment planning system and carried out the dosimetry 
with an amorphous silicon electronic portal imaging device 
(a-Si EPID). The RA delivers a precisely sculpted 3D dose 
distribution with 360-degree rotation of the linear 
accelerator gantry, and hence the conventional cumulative 
dosimetry based QA tools may miss instant deviations from 
the planned delivery at specific gantry angles or control 
points. To overcome this problem, we divided a counter 
clockwise (CCW) and clockwise (CW) Rapid Arc of 358' 
delivery into 7 small sub arcs of 50´ each in Eclipse 
treatment planning system, and measured these sub arcs 
using amorphous silicon electronic portal imaging device (a-Si 
EPID). We analysed these sub arcs and composite arc EPID 
dose fluence using the portal dosimetry software. We also 
analysed the cumulative dose image generated by summation 
of all sub arcs. A total of 20 Rapid Arc Patient planning were 
analysed for this study. 
Results: The gamma index (DTA: 3.0 mm Tolerance: 3.0 %) 
evaluated by us indicated good correlation between 
predicted and acquired EPID images for a complete arc with a 
few differences in high gradient areas. In the case of sub arc 
QA, it was found that gamma index was violated in a two 
patients with one sub Arc for Area Gamma < 1.0 is 65.3% and 
88.9 %, where tolerance is 95.0 %. Interestingly, for these 
patients the cumulative QA results showed no violation. 
Conclusions: It is, therefore, concluded that QA of RA plans 
based on sub arcs methods should be part of the overall QA 
process. Specially for complex treatment plan where we are 
trying to save critical organ vary close proximity of target 
using Rapid Arc. So we found the a-Si EPID -based pre-
treatment RA verification method to be a good quality 
assurance (QA) procedure for the purpose. 
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Purpose/Objective: The aim of this study is to test the 
accuracy of the dose calculation algorithm available in 
DosimetryCheck (DC, MathResolution®), a patient QA 
software. 
Materials and Methods: DC allows for both pre-treatment QA 
and in vivo dose verification, using the EPID measured 
fluence of the treatment fields to reconstruct the dose 
distribution in the CT planning model of the patient. First 
tests were performed on the IBA 'I'm RT' phantom to assess 
DC performances in the steps of entrance fluence estimation 
and dose calculation. The central cubic insert was filled in 
three different ways: homogeneously with RW3 slabs 
(phantom H) or replacing the central slabs with air (phantom 
A) or bone inserts (phantom B). The accuracy of entrance 
fluence estimation independently of the irradiated object 
was evaluated acquiring EPID data in vivo and pre treatment 
on the three phantoms for different square field sizes (FS) 
and then evaluating the isocenter dose in phantom H with 
DC. The global accuracy was assessed by comparing OFs and 
PDDs evaluated with TPS with that reconstructed by DC. 
Finally, DC was run on pre-treatment and in-vivo images of 15 
patients: 1) 7 IMRT prostate cases, 2) 3 abdominal VMAT 
cases, 3) 5 head VMAT cases. Gamma analysis (3%, 3mm) was 
used to compare measured with calculated dose distribution.  
Results: Average absolute differences of isocenter doses in 
phantom H obtained with DC from in vivo measurement with 
respect to that obtained from pre treatment measurement 
were 0.43%, 0.82% and 0.92% for B, H and A phantoms 
respectively. Maximum deviation (1.75%) was observed for 
phantom A and 3.2 cm FS. Pre treatment measurements 
produced relative differences on OFs between 0.01/0.53%. H 
and B phantoms gave similar values (-0.48/0.92%, and 
0.70/0.80% respectively). Due to the use of a pencil beam 
algorithm (PB), higher differences were found in phantom A, 
especially for small fields (64.2% for 2.4 cm FS vs -2.1% for 
15.2 cm FS). The effects of the PB were also observed on the 
PDDs. For H and B phantoms, the percent difference 
remained within 1/1.5% at all depths (exception for the 
buildup region) for the 3.2 and 10.4 cm FSs respectively. For 
the A phantom, DC overestimated the dose up to 12% and 
110% in the air thickness for the 10.4 cm and 2.4 cm field 
size respectively. Patients results are summarised in table 
1.For each patient the value of the dose difference at the 
isocenter, PTV and patient gamma passing rates are 
reported. The in vivo values are the average values of the 
treatment sessions acquired. The worst result has been 
obtained for PTV pre and in vivo head treatment where the 
DC algorithm fails due to air in the nasal cavity.  
 
